Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Dr João Pedro Marques

In this page

Member info

Dr João Pedro Marques

Substitute

Portugal

Working Group(s): Retinal Rare Eye Diseases (WG1), Research (TWG8), National Integration (TWG9)

Team

Prof Joaquim Murta

Portugal

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8)
See more

Joao Quadrado Gil

Portugal

Anterior Segment Rare Eye Diseases (WG4), Registries & Epidemiology (TWG7), Research (TWG8)
See more

Dr Pedro Fonseca

Portugal

Neuro-Ophthalmology Rare Diseases (WG2)
See more

Dr Jorge Henriques

Portugal

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), National Integration (TWG9), Research (TWG8)
See more

Dr Raimundo Miguel

Portugal

Anterior Segment Rare Eye Diseases (WG4), Neuro-Ophthalmology Rare Diseases (WG2), Registries & Epidemiology (TWG7), Research (TWG8)
See more

Dr Catarina Paiva

Portugal

Low Vision Daily Life and Patients Groups (TWG5), Pediatric Ophthalmology Rare Diseases (WG3)
See more

Pr Rufino Silva

Portugal

Genetic Diagnostics (TWG6), National Integration (TWG9), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

HCP Center

CHUC's mission is to provide high quality and differentiated health care in a context of training, teaching, research, scientific knowledge and...

contact

Centro Hospitalar e Universitário de Coimbra – CHUC, Coimbra, Portugal

Praceta Professor Mota Pinto
3004-561 Coimbra
Portugal

Clinical trials

NCT03584243 Unknown

Transepithelial Corneal Collagen Crosslinking in Eyes With Progressive Keratoconus.

Interventional
See the trial
voir la fiche
NCT04423718 Active, Not recruiting

Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche

NCT05642312 Recruiting, Active

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema

Interventional
See the trial
voir la fiche
NCT03992417 Active, Not recruiting

A Prospective Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis

Observational
See the trial
voir la fiche

Scientific publications

The need for widely available genomic testing in rare eye diseases: an ERN‑EYE position statement

ERN-EYE promotes access to genetic testing in RED and emphasizes the clinical need and relevance of genetic testing in...

Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a 2-Year Follow-Up Multinational Survey by the European Vision Institute Clinical Research Network – EVICR.net

This second multinational survey on management of IRDs in Europe highlights persistent important differences in the number of IRD patients managed...

PDF - 1 MB

Current Management of Patients with RPE65 Mutation Associated Inherited Retinal Degenerations in Europe: Results of a 2-Year Follow-Up Multinational Survey

An electronic survey questionnaire with 48 questions specifically addressing RPE65-IRD (2019 survey 35) was developed and sent by June 2021 to 95...

PDF - 665 KB

Mutational Spectrum, Ocular and Olfactory Phenotypes of CNGB1-Related RP-Olfactory Dysfunction Syndrome in a Multiethnic Cohort

Our study supports previous reports of an autosomal recessive RP-olfactory dysfunction syndrome in association with certain disease-causing...